Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT02955498
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects
32
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Healthy Male Subjects
Completed
NCT00403481
An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes
192
Enrollment(s)
0
Study location(s)
Interventional (Phase IV)
Hypertension
Completed
NCT02621957
Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential
15
Enrollment(s)
0
Study location(s)
Interventional (Phase I)
Breast Cancer
Completed
NCT00147797
Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral Therapy
84
Enrollment(s)
1
Study location(s)
Observational
HIV Infection
Carotid Atherosclerosis
Dyslipidemia
Completed
NCT01852214
Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes
50
Enrollment(s)
1
Study location(s)
Interventional (Not Applicable)
Diabetes Mellitus
Coronary Artery Disease
Completed
NCT01700322
Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study
126
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Unknown status
NCT02869984
Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection Syndrome
100
Enrollment(s)
0
Study location(s)
Interventional (Early Phase I)
Anterior Resection Syndrome
Terminated
NCT01790854
BLeeding Events and Maintenance DoSe of PraSugrel
195
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Adverse Reaction to Antiplatelet Agent
Acute Coronary Syndrome
81
82
83
84
85